» Articles » PMID: 19168740

Preferential Brain Homing Following Intranasal Administration of Trypanosoma Cruzi

Overview
Journal Infect Immun
Date 2009 Jan 27
PMID 19168740
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The Chagas' disease parasite Trypanosoma cruzi commonly infects humans through skin abrasions or mucosa from reduviid bug excreta. Yet most studies on animal models start with subcutaneous or intraperitoneal injections, a distant approximation of the skin abrasion route. We show here that atraumatic placement of T. cruzi in the mouse nasal cavity produced low parasitemia, high survival rates, and preferential brain invasion compared to the case with subcutaneously injected parasites. Brain invasion was particularly prominent in the basal ganglia, peaked at a time when parasitemia was no longer detectable, and elicited a relatively large number of inflammatory foci. Yet, based on motor behavioral parameters and staining with Fluoro-Jade C, a dye that specifically recognizes apoptotic and necrotic neurons, brain invasion did not cause neurodegenerative events, in contrast to the neurodegeneration in the enteric nervous system. The results indicate that placement of T. cruzi on the mucosa in the mouse nasal cavity establishes a systemic infection with a robust yet harmless infection of the brain, seemingly analogous to disease progression in humans. The model may facilitate studies designed to understand mechanisms underlying T. cruzi infection of the central nervous system.

Citing Articles

Central Nervous System Infection-Pathogenesis, Clinical Manifestations, Diagnosis, and Treatment.

Olivo-Freites C, Sy H, Cardenas-Alvarez J, Vega-Batista F, Henao-Martinez A Curr Trop Med Rep. 2024; 10(4):186-198.

PMID: 38983718 PMC: 11233130. DOI: 10.1007/s40475-023-00300-0.


Anxiety, depression, and memory loss in Chagas disease: a puzzle far beyond neuroinflammation to be unpicked and solved.

Lannes-Vieira J, Vilar-Pereira G, Barrios L, Silva A Mem Inst Oswaldo Cruz. 2023; 118:e220287.

PMID: 37018799 PMC: 10072003. DOI: 10.1590/0074-02760220287.


Central nervous system commitment in Chagas disease.

Useche Y, Perez A, de Meis J, Bonomo A, Savino W Front Immunol. 2022; 13:975106.

PMID: 36439149 PMC: 9685529. DOI: 10.3389/fimmu.2022.975106.


Endothelins in inflammatory neurological diseases.

DOrleans-Juste P, Akide Ndunge O, Desbiens L, Tanowitz H, Desruisseaux M Pharmacol Ther. 2018; 194:145-160.

PMID: 30291906 PMC: 6348026. DOI: 10.1016/j.pharmthera.2018.10.001.


Oral Versus Intragastric Inoculation: Similar Pathways of Experimental Infection? From Target Tissues, Parasite Evasion, and Immune Response.

Barreto de Albuquerque J, Silva Dos Santos D, Stein J, de Meis J Front Immunol. 2018; 9:1734.

PMID: 30100907 PMC: 6072848. DOI: 10.3389/fimmu.2018.01734.


References
1.
Leiguarda R, RONCORONI A, Taratuto A, Jost L, Berthier M, Nogues M . Acute CNS infection by Trypanosoma cruzi (Chagas' disease) in immunosuppressed patients. Neurology. 1990; 40(5):850-1. DOI: 10.1212/wnl.40.5.850. View

2.
Hunter C, Slifer T, Araujo F . Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon. Infect Immun. 1996; 64(7):2381-6. PMC: 174086. DOI: 10.1128/iai.64.7.2381-2386.1996. View

3.
Rosemberg S, Chaves C, Higuchi M, Lopes M, Castro L, Machado L . Fatal meningoencephalitis caused by reactivation of Trypanosoma cruzi infection in a patient with AIDS. Neurology. 1992; 42(3 Pt 1):640-2. DOI: 10.1212/wnl.42.3.640. View

4.
Adad S, Cancado C, Etchebehere R, Teixeira V, Gomes U, CHAPADEIRO E . Neuron count reevaluation in the myenteric plexus of chagasic megacolon after morphometric neuron analysis. Virchows Arch. 2001; 438(3):254-8. DOI: 10.1007/s004280000319. View

5.
Arantes R, Marche H, Bahia M, Cunha F, Rossi M, Silva J . Interferon-gamma-induced nitric oxide causes intrinsic intestinal denervation in Trypanosoma cruzi-infected mice. Am J Pathol. 2004; 164(4):1361-8. PMC: 1615344. DOI: 10.1016/s0002-9440(10)63222-1. View